The association between HLA-B variants and amoxicillin-induced severe cutaneous adverse reactions in Chinese han population
- PMID: 38863977
- PMCID: PMC11165025
- DOI: 10.3389/fphar.2024.1400239
The association between HLA-B variants and amoxicillin-induced severe cutaneous adverse reactions in Chinese han population
Abstract
Background: Amoxicillin (AMX) is among the most prescribed and the best tolerated antimicrobials worldwide. However, it can occasionally trigger severe cutaneous adverse reactions (SCAR) with a significant morbidity and mortality. The genetic factors that may be relevant to AMX-induced SCAR (AMX-SCAR) remain unclear. Identification of the genetic risk factor may prevent patients from the risk of AMX exposure and resume therapy with other falsely implicated drugs.
Methodology: Four patients with AMX-SCAR, 1,000 population control and 100 AMX-tolerant individuals were enrolled in this study. Both exome-wide and HLA-based association studies were conducted. Molecular docking analysis was employed to simulate the interactions between AMX and risk HLA proteins.
Results: Compared with AMX-tolerant controls, a significant association of HLA-B*15:01 with AMX-SCAR was validated [odds ratio (OR) = 22.9, 95% confidence interval (CI): 1.68-1275.67; p = 7.34 × 10-3]. Moreover, 75% carriers of HLA-B*15:01 in four patients with AMX-SCAR, and the carrier frequency of 10.7% in 1,000 control individuals and 11.0% in 100 AMX-tolerant controls, respectively. Within HLA-B protein, the S140 present in all cases and demonstrated the strongest association with AMX-SCAR [OR = 53.5, p = 5.18 × 10-4]. Molecular docking results also confirmed the interaction between AMX and S140 of the HLA-B protein, thus eliminating the false-positive results during in association analysis.
Conclusion: Our findings suggest that genetic susceptibility may be involved in the development of AMX-SCAR in Han Chinese. However, whether the HLA-B variants observed in this study can be used as an effective genetic marker of AMX-induced SCAR still needs to be further explored in larger cohort studies and other ethnic populations.
Keywords: HLA-B; amoxicillin; severe cutaneous adverse reactions; variants; whole-exome sequencing.
Copyright © 2024 Wang, Yang, Yang, Cheng, Huang, Li, Yang, Xing and Luo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong.Br J Dermatol. 2012 Jul;167(1):44-9. doi: 10.1111/j.1365-2133.2012.10894.x. Epub 2012 May 8. Br J Dermatol. 2012. PMID: 22348415
-
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412. doi: 10.1016/j.jaci.2020.08.003. Epub 2020 Aug 10. J Allergy Clin Immunol. 2021. PMID: 32791162
-
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9. doi: 10.1073/pnas.0409500102. Epub 2005 Mar 2. Proc Natl Acad Sci U S A. 2005. PMID: 15743917 Free PMC article.
-
Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.Oncotarget. 2016 Dec 6;7(49):81870-81879. doi: 10.18632/oncotarget.13250. Oncotarget. 2016. PMID: 27835909 Free PMC article. Review.
-
Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.JAMA Dermatol. 2018 Apr 1;154(4):441-446. doi: 10.1001/jamadermatol.2017.6484. JAMA Dermatol. 2018. PMID: 29541744 Free PMC article.
References
-
- Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schroder W., Roujeau J. C., et al. (2002). Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch. Dermatol 138, 1019–1024. 10.1001/archderm.138.8.1019 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials